FONT-SIZE Plus   Neg

Pre-market Movers For March 26 (YHOO, AMGN, ARNA, VRNM, TEVA, CALM, AUDC)


Yahoo! Inc. (YHOO) is up 0.62 percent to $15.48. The company appointed three new independent directors, effective April 5, 2012: John Hayes, Peter Liguori and Thomas McInerney. The company stated that appointing Third Point founder and Chief Executive Officer Daniel Loeb to its Board is not in the best interest of company and shareholders. Third Point responded that it is disappointed by the company's announcement and intends to move forward with a proxy contest.

Amgen Inc. (AMGN) is gaining over 1 percent to $67.83. The company announced positive results from a phase Ib study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study revealed that multiple doses of the drug significantly reduced LDL, or bad cholesterol, by up to 81 percent compared to placebo in patients on low to moderate doses of statins.

Arena Pharmaceuticals, Inc. (ARNA) is up nearly 9 percent to $2.62. The company announced European Medicines Agency's acceptance of Lorcaserin Marketing Authorization Application for weight control. The company also received FDA confirmation of May 10th Lorcaserin Advisory Committee Meeting.

Verenium Corp. (VRNM) is rising 29 percent to $4. The company announced it has closed a $37 Million sale of certain assets to Royal DSM. Verenium said it will receive $37 million in total consideration, including transaction and related expenses today.

Teva Pharmaceutical Industries Ltd. (TEVA) is up over 1 percent to $43.65. The company announced FDA approval for QNASLTM Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.


Cal-Maine Foods Inc. (CALM) is down over 2 percent to $40.90. The company's third quarter profit declined from the previous year. Net sales improved from the previous year.

Trading halt:

Trading in shares of AudioCodes Ltd. (AUDC) was halted.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Shares of Orange SA (ORAN) were gaining around 5 percent in the morning trading in Paris after the French telecom major reported higher restated EBITDA, a key earnings metric, in its third quarter with slightly higher sales. This was despite weakness in its domestic market. Further, the company maintained its fiscal 2016 forecast of restated EBITDA to be greater than last year, on a comparable bas Swiss drug giant Novartis AG reported Tuesday higher net profit in its third quarter, while sales were weak due to generic competition and pricing. Core earnings per share topped analysts' estimates, but sales missed their view. For fiscal 2016, the company continues to expect Core operating income to be broadly in line or decline low-single digit, and net sales to be broadly in line.. Social media site Twitter Inc., which is facing an uncertain future, is planning to cut around 8 percent of its total workforce, Bloomberg reported Monday citing people familiar with the matter. The company, which is trying cost control amid slowing sales growth, may announce the job cut of about 300 people as soon as this week.
comments powered by Disqus
Follow RTT